Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: A case report

被引:2
作者
Chams S. [1 ]
Hajj Hussein I. [2 ]
El Sayegh S. [1 ]
Chams N. [1 ]
Zakaria K. [1 ]
机构
[1] Department of Internal Medicine, Wayne State University, School of Medicine, Rochester Hills, MI
[2] Department of Biomedical Sciences, Oakland University, William Beaumont School of Medicine, Rochester, MI
关键词
AITL; Angioimmunoblastic T cell lymphoma; Hypercalcemia;
D O I
10.1186/s13256-018-1669-0
中图分类号
学科分类号
摘要
Background: Angioimmunoblastic T cell lymphoma is a rare malignancy, accounting for only 2% of all non-Hodgkin lymphomas, first described in the 1970s and subsequently accepted as a distinct entity in the current World Health Organization classification. Due to the paucity of this disease, there is still no identifiable etiology, no consistent risk factors, and the pathogenesis remains unclear. Case presentation: An 83-year-old Caucasian man presented to an emergency department with palpitations and was found to have atrial fibrillation. During his hospitalization, he was found to have asymptomatic hypercalcemia with corrected calcium of 11.7. Ten days later while in rehabilitation, he started complaining of progressive fatigue and altered mental status was noted. He was found to have a calcium level of 15.5 and was admitted to the intensive care unit for management and further workup. He was found at that time to have, parathyroid hormone: < 1; 25 hydroxyvitamin D: 74; 1,25 dihydroxyvitamin D: 85.4; angiotensin-converting enzyme: 7; parathyroid hormone-related protein: < 2; and multiple myeloma workup was negative. Computed tomography of his chest and abdomen showed extensive retroperitoneal, pelvic, and mesenteric lymphadenopathy in addition to findings suggestive of peritoneal carcinomatosis. A right axillary lymph node biopsy showed immunohistochemical parameters consistent with angioimmunoblastic T cell lymphoma. After a lengthy discussion with his family, it was decided that no further treatment would be pursued. He had an aggressive course at the hospital during which he developed pleural effusions, ascites, and diffuse petechiae within 2 weeks; these were complications from his malignancy. Considering the poor outcomes of his aggressive disease, he decided to enroll in an out-patient hospice. He died within a few months as a result of cardiorespiratory arrest. Conclusions: This case illustrates a rare presentation of an extremely rare disease; that is, hypercalcemia in a patient who was later found to have angioimmunoblastic T cell lymphoma. Diagnosing angioimmunoblastic T cell lymphoma might be the most challenging part due to the wide array of clinical presentations, of which hypercalcemia accounts for only 1%. As seen in this case, most patients present in advanced stages of the disease with poor prognosis. © 2018 The Author(s).
引用
收藏
相关论文
共 9 条
[1]  
Tobinai K., Minato K., Ohtsu T., Mukai K., Kagami Y., Miwa M., Watanabe S., Shimoyama M., Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma, Blood, 72, pp. 1000-1006, (1988)
[2]  
Siegert W., Agthe A., Griesser H., Schwerdtfeger R., Brittinger G., Engelhard M., Kuse R., Tiemann M., Lennert K., Huhn D., Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group, Ann Intern Med, 117, pp. 364-370, (1992)
[3]  
Pautier P., Devidas A., Delmer A., Dombret H., Sutton L., Zini J.M., Nedelec G., Molina T., Marolleau J.P., Brice P., Angioimmunoblastic-like T-cell non-Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature, Leuk Lymphoma, 32, pp. 545-552, (1999)
[4]  
Federico M., Rudiger T., Bellei M., Et al., Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project, J Clin Oncol, 31, 2, pp. 240-246, (2013)
[5]  
Mundy G., Edwards J., PTH-Related Peptide (PTHrP) in Hypercalcemia, J Am Soc Nephrol, 19, 4, pp. 672-675, (2008)
[6]  
Hewison M., Kantorovich V., Liker H., Et al., Vitamin D-Mediated Hypercalcemia in Lymphoma: Evidence for Hormone Production by Tumor-Adjacent Macrophages, J Bone Miner Res, 18, 3, pp. 579-582, (2003)
[7]  
Tebben P., Singh R., Kumar R., Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment, Endocr Rev, 37, 5, pp. 521-547, (2016)
[8]  
Dogan A., Attygalle A., Kyriakou C., Angioimmunoblastic T-cell lymphoma, Br J Haematol, 121, 5, pp. 681-691, (2003)
[9]  
Iannitto E., Ferreri A., Minardi V., Tripodo C., Kreipe H., Angioimmunoblastic T-cell lymphoma, Crit Rev Oncol Hematol, 68, 3, pp. 264-271, (2008)